0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tazobactam"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$5,850USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
EUR$7,660USDGBP
From
EUR$2,600USDGBP
From
EUR$4,750USDGBP
  • 7 Results (Page 1 of 1)
Loading Indicator

Tazobactam is an antibiotic used in combination with other antibiotics to treat a variety of bacterial infections. It is a beta-lactamase inhibitor, which means it prevents bacteria from breaking down the antibiotics, allowing them to work more effectively. Tazobactam is often used in combination with piperacillin, a broad-spectrum antibiotic, to treat serious infections such as pneumonia, sepsis, and urinary tract infections. It is also used to treat infections caused by multi-drug resistant bacteria. Tazobactam is available in both injectable and oral forms, and is approved for use in adults and children. It is generally well-tolerated, with few side effects. However, it can cause allergic reactions in some people. The tazobactam market is a growing segment of the antibiotics market, as it is increasingly used to treat multi-drug resistant infections. It is also used in combination with other antibiotics to treat a variety of bacterial infections. Some companies in the tazobactam market include Merck, Pfizer, GlaxoSmithKline, and AstraZeneca. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more